Dolby Laboratories (NYSE:DLB) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, October 25th. Analysts expect the company to announce earnings of $0.28 per share for the quarter. Dolby Laboratories has set its Q4 guidance at $0.36 to $0.42 EPS.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Tuesday, July 25th. The electronics maker reported $0.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.10. The company had revenue of $305.67 million for the quarter, compared to analysts’ expectations of $296.88 million. Dolby Laboratories had a net margin of 19.02% and a return on equity of 10.25%. Dolby Laboratories’s revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.62 EPS. On average, analysts expect Dolby Laboratories to post $1.99 EPS for the current fiscal year and $2.23 EPS for the next fiscal year.

Dolby Laboratories (NYSE DLB) opened at 59.20 on Wednesday. The firm has a market capitalization of $6.07 billion, a PE ratio of 30.28 and a beta of 0.84. Dolby Laboratories has a 52 week low of $44.99 and a 52 week high of $59.79. The firm has a 50-day moving average of $55.70 and a 200 day moving average of $52.17.

COPYRIGHT VIOLATION WARNING: “Dolby Laboratories (DLB) Scheduled to Post Quarterly Earnings on Wednesday” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/10/18/dolby-laboratories-dlb-scheduled-to-post-quarterly-earnings-on-wednesday.html.

In other news, EVP Mark Andrew Sherman sold 14,000 shares of the firm’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $56.25, for a total transaction of $787,500.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Kevin J. Yeaman sold 45,000 shares of the firm’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $56.46, for a total value of $2,540,700.00. The disclosure for this sale can be found here. Insiders sold 1,419,000 shares of company stock worth $71,701,100 over the last quarter. 43.80% of the stock is currently owned by company insiders.

An institutional investor recently raised its position in Dolby Laboratories stock. The Manufacturers Life Insurance Company grew its holdings in shares of Dolby Laboratories (NYSE:DLB) by 25.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,564 shares of the electronics maker’s stock after purchasing an additional 725 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Dolby Laboratories were worth $174,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 51.87% of the company’s stock.

DLB has been the topic of a number of recent research reports. BidaskClub cut Dolby Laboratories from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 22nd. Dougherty & Co reiterated a “buy” rating and issued a $63.00 target price on shares of Dolby Laboratories in a research note on Wednesday, September 13th. B. Riley reiterated a “buy” rating and issued a $61.50 target price on shares of Dolby Laboratories in a research note on Thursday, September 14th. Piper Jaffray Companies reiterated a “hold” rating and issued a $52.00 target price (up from $49.00) on shares of Dolby Laboratories in a research note on Wednesday, September 13th. Finally, Zacks Investment Research upgraded Dolby Laboratories from a “sell” rating to a “hold” rating in a research note on Tuesday, July 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company’s stock. Dolby Laboratories currently has an average rating of “Hold” and an average target price of $58.83.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Earnings History for Dolby Laboratories (NYSE:DLB)

Receive News & Stock Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related stocks with our FREE daily email newsletter.